The partnership with Script Assist is a significant move for Aurora Cannabis, expanding its footprint in the UK medical cannabis market. The introduction of new products and the collaboration's focus on improving patient access and education are likely to be viewed positively by investors, as reflected in the stock's price increase post-announcement. This strategic move could enhance Aurora's market position and revenue potential in the UK, contributing to the positive short-term impact on its stock.